OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 01, 2021
The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.
February 09, 2021
Model-based approaches and digital analytics are improving flexibility at both the equipment and the manufacturing-line level.
February 04, 2021
PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.
February 02, 2021
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.
February 01, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
January 05, 2021
Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.
January 02, 2021
Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.
November 23, 2020
The partners have established PathoQuest, Inc., a US subsidiary, and will construct an NGS-based testing lab at Charles River’s Wayne, PA, site.
October 07, 2020
Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.